HealthTech
PureHealth Posts AED 1.8 Billion Nine-Month Profit, Up 14.1% Year on Year
PureHealth Holding PJSC reported a 14.1% year-on-year increase in net profit to 1.8 billion United Arab Emirates dirhams (AED) for the nine months ended September 30, 2026, as group revenue rose 11.5% to AED 22.4 billion, according to the company’s…
Dexcom Raises 2026 Outlook as Q3 Revenue Grows 11% to $1.344 Billion
DexCom, Inc. reported revenue of US$1.344 billion for the third quarter ended September 30, 2026, an 11% increase from $1.209 billion a year earlier, and paired the results with a raised full-year 2026 outlook and a new share repurchase authorization…
Abbott Amplatzer Paraclose PVL Occluder Wins FDA Approval
Abbott announced on October 28, 2026, that it has received U.S. Food and Drug Administration approval for the Amplatzer Paraclose PVL Occluder, a transcatheter device designed to treat paravalvular leak (PVL), a backflow of blood around a surgical heart valve.…
Dexcom Brings 15-Day G7 Glucose Sensor to Canadian Adults in November
DexCom, Inc. said on October 28, 2026 that its Dexcom G7 15 Day Continuous Glucose Monitoring System will be available in Canada beginning in November 2026 for adults 18 years and older living with diabetes, according to the company’s announcement…
Labcorp Raises 2026 Guidance as Q3 Adjusted EPS Climbs 14.5%
Labcorp Holdings reported revenue of $3.81 billion for the third quarter ended September 30, 2026, up 6.9% from $3.56 billion a year earlier, and raised its full-year 2026 enterprise revenue and adjusted earnings-per-share guidance, according to the company’s third-quarter earnings…
Stryker Closes ZuriMED Acquisition Adding Rotator Cuff Technology
Stryker has completed its acquisition of ZuriMED Technologies AG, the privately held developer of the FiberLocker System, the company announced on October 26, 2026, adding a commercialized rotator cuff augmentation technology to its Sports Medicine portfolio. The Portage, Michigan, medical…
Tempus xR RNA Sequencing Assay Receives EU IVDR Class C Certification
Tempus AI said in an October 26, 2026 announcement that its xR RNA-sequencing assay has received certification under the European Union’s In Vitro Diagnostic Regulation as a Class C in vitro diagnostic device. The Chicago-based company said the certification covers…
Abbott Plans Tax-Free Spinoff of $8.5 Billion Nutrition Business
Abbott announced on October 21, 2026, that it intends to separate its global Nutrition business into an independent, publicly traded company through a distribution of shares to Abbott shareholders. According to Abbott’s announcement, the Nutrition business generates approximately $8.5 billion…
Abbott Wins CE Mark for Cologuard Plus Colorectal Cancer Test
Abbott announced on October 20, 2026, from Abbott Park, Illinois, that the Cologuard Plus test has received CE Mark under the European Union’s In Vitro Diagnostic Medical Devices Regulation (IVDR), and that it plans to introduce the noninvasive, stool-based DNA…
Healthcare Exoskeletons: Robotics That Support Care Workers
The most useful robot in a care home might be one a nurse wears. Rather than replacing the person helping a resident stand, a wearable exoskeleton could support that worker’s back and make repeated physical tasks less demanding. The caregiver…
Medtronic Swaps Remaining MiniMed Stake to Finish Separation
Medtronic plc announced on October 15, 2026 that it has completed the separation of MiniMed Group, Inc. , after exchanging its entire remaining stake in the company through an oversubscribed split-off exchange offer. Medtronic said it elected to exchange all…
GE HealthCare Wins CE Mark for MINItrace Magni Cyclotron
GE HealthCare announced on October 15, 2026, that its MINItrace Magni cyclotron has achieved CE Mark and that its PETtrace Solid Target Platform is expanding beyond Gallium-68 with support for Copper-64 production, according to a company news release. The company…
Sweat Sensors Bring Arthritis Monitoring Closer to Home
As medical technology progresses, more accurate and less invasive diagnostics are a constant goal. For example, the first X-ray, and then ultrasound, MRI, and other scanner technologies have made it possible to detect and assess injuries and other problems without…
Jonathan Schramm
Medtronic Sets MiniMed Split-Off Exchange Ratio at 4.5939 Upper Limit
Medtronic plc on October 7, 2026 announced the final exchange ratio of 4.5939 shares of MiniMed Group, Inc. common stock for each Medtronic ordinary share validly tendered and accepted in its split-off exchange offer, fixing the ratio at the offer’s…
Abbott CardioMEMS Wins FDA Approval for Patient-Facing App Features
Abbott announced on Oct. 5, 2026 that the U.S. Food and Drug Administration has approved updates to the CardioMEMS HF System that enable new patient-facing capabilities through the company’s CardioGuide HF App. For the first time, care teams can allow…
